DMW - Deutsche Medizinische Wochenschrift, Table of Contents Dtsch Med Wochenschr 2013; 138(12): 599DOI: 10.1055/s-0032-1332904 Pro & Contra | Commentary Kardiologie, Genetik © Georg Thieme Verlag KG Stuttgart · New York Die genetische Testung ist der Myokardbiopsie bei Kardiomyopathien überlegen – contra Genetic testing is superior to biopsy of the myocardium in cardiomyopathy – no H. P. Schultheiss Recommend Article Abstract Buy Article Schlüsselwörter Schlüsselwörterhypertrophe Kardiomyopathie (HCM) - dilatative Kardiomyopathie (DCM) - arrhythmogene rechtsven- trikuläre Kardiomyopathie (ARVC) Keywords Keywordshypertrophic cardiomyopathy - dilated cardiomyopathy - arrhythmogenic right ventricular cardiomyopathy Full Text References Literatur 1 Ackermann MJ et al. HSR/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies. Europace 2011; 13: 1077-1109 2 Andreasen C et al. New population-based exome data are questioning the pathogenicity of previously cardiomyopathy-associated genetic variants. Euro J Hum Genet 2013; doi: 3 Frustaci A, Russo MA, Chimenti C. Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J 2009; 30: 1995-2002 4 Kuehl U et al. Interferon-beta- improves survival in enterovirus-associated cardiomyopathy. J Am Coll Cardiol 2012; 60: 1295-1296 5 Schultheiss HP, Kuehl U, Cooper LT. The management of myocarditis. Eur Heart J 2011; 32: 2616-2665 6 van der Zwaag PA, van Tintelen JP. Counsel the genotype, treat the phenotype. Europ J Heart Failure 2011; 13: 1159-1160
